Sigma-Aldrich recently announced that it has released new additions to its Mission TRC RNAi product line. These additions bring the current number of vector constructs offered to 50,000, targeting 7,100 human and 2,900 mouse genes, the company said.
The constructs are available as frozen bacterial glycerol stocks or transfection grade plasmid DNA, Sigma-Aldrich said.
Additional information about the Mission RNAi products can be found at http://www.sigmaaldrich.com/Area_of_Interest/Life_Science/RNA_Interference_RNAi.html.
US Genomics has recently unveiled its Direct Results fee-for-service program, which allows researchers to use single molecule technology to accurately quantitate the microRNAs in their samples.
According to the company, the new service uses the Trilogy 2020 single molecule analyzer to enable scientists to detect individual molecules of miRNA with Direct miRNA assays.